P Raskin, E Allen, P Hollander, A Lewin, RA … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—A total of 209 subjects completed the study. At study end, the mean
HbA 1c value was lower in the BIAsp 70/30 group than in the glargine group (6.91
± 1.17 vs. 7.41 ± 1.24%, P < 0.01). The HbA 1c reduction was greater in ... Cited by 323 - Related articles - All 7 versions
- ►karolinskauniversitetssjukhuset.se [PDF] SR Salpeter, E Greyber, GA Pasternak, EE … - Archives of Internal Medicine, 2003 - archinte.highwire.org Methods A comprehensive search was performed to identify all comparative trials
or observational cohort studies published between January 1, 1959, and March 31,
2002, that evaluated metformin therapy, alone or in combination with other ... Cited by 317 - Related articles - BL Direct - All 16 versions
- ►juanncorpas.edu.co [PDF] DE DeWitt, IB Hirsch - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Newer insulin ... Cited by 273 - Related articles - BL Direct - All 8 versions
- ►pubget.com [PDF] M Freemark, D Bursey - Pediatrics, 2001 - Am Acad Pediatrics Objectives. The prevalence of type 2 diabetes in American adolescents has
increased markedly during the past generation. Although the factors that
contribute to the development of type 2 diabetes are complex and not wholly ... Cited by 234 - Related articles - All 11 versions
- ►endojournals.org S Matthaei, M Stumvoll, M Kellerer, HU Haring - Endocrine Reviews, 2000 - Endocrine Soc Diabetes mellitus type 2 is a world-wide growing health problem affecting more
than 150 million people at the beginning of the new millennium. It is believed
that this number will double in the next 25 yr. The pathophysiological ... Cited by 204 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org [PDF] H Yki-Järvinen - Diabetes Care, 2001 - Am Diabetes Assoc The UK Prospective Diabetes Study (UKPDS) demonstrated that inten- sive glucose
control with insulin or sulfonylureas markedly reduces the risk of microvascular
complications (1). For myocardial infarction, the reduction in risk (16% ... Cited by 203 - Related articles - BL Direct - All 7 versions
EAM Gale - The Lancet, 2001 - Elsevier Troglitazone, the first in the thiazolidinedione class of oral hypoglycaemic
agents, was launched in the USA in March, 1997. It reached Europe later that
year, only to be withdrawn within weeks on the grounds of liver toxicity. ... Cited by 174 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org PA Hollander, P Levy, MS Fineman, DG Maggs … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—Treatment with pramlintide 120 μg BID led to a sustained reduction
from baseline in HbA 1c (−0.68 and −0.62% at weeks 26 and 52, respectively),
which was significantly greater than that seen with placebo (P < 0.05). The ... Cited by 167 - Related articles - BL Direct - All 5 versions
H Yki-Järvinen, R Kauppinen-Mäkelin, M … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 442–451 DOI 10.1007/s00125-005-0132-0 ARTICLE H.
Yki-Järvinen . R. Kauppinen-Mäkelin . M. Tiikkainen . M. Vähätalo . ... Cited by 156 - Related articles - BL Direct - All 7 versions
V Fonseca - The American journal of medicine, 2003 - Elsevier Treatment of diabetes mellitus with medications, including insulin,
sulfonylureas, and thiazolidinediones (TZDs), often leads to weight gain through
a variety of mechanisms. Weight gain can have adverse consequences for ... Cited by 107 - Related articles - All 8 versions
